240 related articles for article (PubMed ID: 18560571)
1. Suppression of tumor growth and angiogenesis by a specific antagonist of the cell-surface expressed nucleolin.
Destouches D; El Khoury D; Hamma-Kourbali Y; Krust B; Albanese P; Katsoris P; Guichard G; Briand JP; Courty J; Hovanessian AG
PLoS One; 2008 Jun; 3(6):e2518. PubMed ID: 18560571
[TBL] [Abstract][Full Text] [Related]
2. Targeting surface nucleolin with multivalent HB-19 and related Nucant pseudopeptides results in distinct inhibitory mechanisms depending on the malignant tumor cell type.
Krust B; El Khoury D; Nondier I; Soundaramourty C; Hovanessian AG
BMC Cancer; 2011 Aug; 11():333. PubMed ID: 21812966
[TBL] [Abstract][Full Text] [Related]
3. Targeting surface nucleolin with a multivalent pseudopeptide delays development of spontaneous melanoma in RET transgenic mice.
El Khoury D; Destouches D; Lengagne R; Krust B; Hamma-Kourbali Y; Garcette M; Niro S; Kato M; Briand JP; Courty J; Hovanessian AG; Prévost-Blondel A
BMC Cancer; 2010 Jun; 10():325. PubMed ID: 20573279
[TBL] [Abstract][Full Text] [Related]
4. Suppression of tumorigenicity of rhabdoid tumor derived G401 cells by the multivalent HB-19 pseudopeptide that targets surface nucleolin.
Krust B; El Khoury D; Soundaramourty C; Nondier I; Hovanessian AG
Biochimie; 2011 Mar; 93(3):426-33. PubMed ID: 21040752
[TBL] [Abstract][Full Text] [Related]
5. The cell surface expressed nucleolin is a glycoprotein that triggers calcium entry into mammalian cells.
Losfeld ME; Khoury DE; Mariot P; Carpentier M; Krust B; Briand JP; Mazurier J; Hovanessian AG; Legrand D
Exp Cell Res; 2009 Jan; 315(2):357-69. PubMed ID: 19026635
[TBL] [Abstract][Full Text] [Related]
6. The pseudopeptide HB-19 binds to cell surface nucleolin and inhibits angiogenesis.
Birmpas C; Briand JP; Courty J; Katsoris P
Vasc Cell; 2012 Dec; 4(1):21. PubMed ID: 23265284
[TBL] [Abstract][Full Text] [Related]
7. Cell-surface nucleolin acts as a central mediator for carcinogenic, anti-carcinogenic, and disease-related ligands.
Fujiki H; Watanabe T; Suganuma M
J Cancer Res Clin Oncol; 2014 May; 140(5):689-99. PubMed ID: 24469254
[TBL] [Abstract][Full Text] [Related]
8. Cell surface nucleolin antagonist causes endothelial cell apoptosis and normalization of tumor vasculature.
Fogal V; Sugahara KN; Ruoslahti E; Christian S
Angiogenesis; 2009; 12(1):91-100. PubMed ID: 19225898
[TBL] [Abstract][Full Text] [Related]
9. Nucleolin mediates the antiangiogenesis effect of the pseudopeptide N6L.
Birmpas C; Briand JP; Courty J; Katsoris P
BMC Cell Biol; 2012 Nov; 13():32. PubMed ID: 23146273
[TBL] [Abstract][Full Text] [Related]
10. Nucleolin Targeting Impairs the Progression of Pancreatic Cancer and Promotes the Normalization of Tumor Vasculature.
Gilles ME; Maione F; Cossutta M; Carpentier G; Caruana L; Di Maria S; Houppe C; Destouches D; Shchors K; Prochasson C; Mongelard F; Lamba S; Bardelli A; Bouvet P; Couvelard A; Courty J; Giraudo E; Cascone I
Cancer Res; 2016 Dec; 76(24):7181-7193. PubMed ID: 27754848
[TBL] [Abstract][Full Text] [Related]
11. Surface expressed nucleolin is constantly induced in tumor cells to mediate calcium-dependent ligand internalization.
Hovanessian AG; Soundaramourty C; El Khoury D; Nondier I; Svab J; Krust B
PLoS One; 2010 Dec; 5(12):e15787. PubMed ID: 21203423
[TBL] [Abstract][Full Text] [Related]
12. The anti-HIV pentameric pseudopeptide HB-19 binds the C-terminal end of nucleolin and prevents anchorage of virus particles in the plasma membrane of target cells.
Nisole S; Said EA; Mische C; Prevost MC; Krust B; Bouvet P; Bianco A; Briand JP; Hovanessian AG
J Biol Chem; 2002 Jun; 277(23):20877-86. PubMed ID: 11919179
[TBL] [Abstract][Full Text] [Related]
13. Surface nucleolin participates in both the binding and endocytosis of lactoferrin in target cells.
Legrand D; Vigié K; Said EA; Elass E; Masson M; Slomianny MC; Carpentier M; Briand JP; Mazurier J; Hovanessian AG
Eur J Biochem; 2004 Jan; 271(2):303-17. PubMed ID: 14717698
[TBL] [Abstract][Full Text] [Related]
14. The anti-HIV pseudopeptide HB-19 forms a complex with the cell-surface-expressed nucleolin independent of heparan sulfate proteoglycans.
Nisole S; Krust B; Callebaut C; Guichard G; Muller S; Briand JP; Hovanessian AG
J Biol Chem; 1999 Sep; 274(39):27875-84. PubMed ID: 10488134
[TBL] [Abstract][Full Text] [Related]
15. A novel receptor - ligand pathway for entry of Francisella tularensis in monocyte-like THP-1 cells: interaction between surface nucleolin and bacterial elongation factor Tu.
Barel M; Hovanessian AG; Meibom K; Briand JP; Dupuis M; Charbit A
BMC Microbiol; 2008 Sep; 8():145. PubMed ID: 18789156
[TBL] [Abstract][Full Text] [Related]
16. Antagonist of nucleolin, N6L, inhibits neovascularization in mouse models of retinopathies.
Darche M; Cossutta M; Caruana L; Houppe C; Gilles ME; Habert D; Guilloneau X; Vignaud L; Paques M; Courty J; Cascone I
FASEB J; 2020 Apr; 34(4):5851-5862. PubMed ID: 32141122
[TBL] [Abstract][Full Text] [Related]
17. Nucleolin antagonist triggers autophagic cell death in human glioblastoma primary cells and decreased in vivo tumor growth in orthotopic brain tumor model.
Benedetti E; Antonosante A; d'Angelo M; Cristiano L; Galzio R; Destouches D; Florio TM; Dhez AC; Astarita C; Cinque B; Fidoamore A; Rosati F; Cifone MG; Ippoliti R; Giordano A; Courty J; Cimini A
Oncotarget; 2015 Dec; 6(39):42091-104. PubMed ID: 26540346
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of angiogenesis and angiogenesis-dependent tumor growth by the cryptic kringle fragments of human apolipoprotein(a).
Kim JS; Chang JH; Yu HK; Ahn JH; Yum JS; Lee SK; Jung KH; Park DH; Yoon Y; Byun SM; Chung SI
J Biol Chem; 2003 Aug; 278(31):29000-8. PubMed ID: 12746434
[TBL] [Abstract][Full Text] [Related]
19. Targeted therapy of human glioblastoma via delivery of a toxin through a peptide directed to cell surface nucleolin.
Dhez AC; Benedetti E; Antonosante A; Panella G; Ranieri B; Florio TM; Cristiano L; Angelucci F; Giansanti F; Di Leandro L; d'Angelo M; Melone M; De Cola A; Federici L; Galzio R; Cascone I; Raineri F; Cimini A; Courty J; Giordano A; Ippoliti R
J Cell Physiol; 2018 May; 233(5):4091-4105. PubMed ID: 28941284
[TBL] [Abstract][Full Text] [Related]
20. Nucleolin antisense oligodeoxynucleotides induce apoptosis and may be used as a potential drug for nasopharyngeal carcinoma therapy.
Wu CD; Chou HW; Kuo YS; Lu RM; Hwang YC; Wu HC; Lin CT
Oncol Rep; 2012 Jan; 27(1):94-100. PubMed ID: 21956494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
